Araceli Biosciences Inc. — Form D

Araceli Biosciences Inc. of TIGARD, OR, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-26. The offering totals $4.0M, of which $2.2M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
William B CortelyouDirectorTigard, OR
J. William FreytagDirectorTigard, OR
Kevin William GabeleinDirectorTigard, OR
Kirk William MalloyDirectorTigard, OR
Sean William O'NeillDirectorTigard, OR
Samraat William RahaDirectorTigard, OR
Bruce William RhineDirectorTigard, OR
Jeff William HarrisExecutive OfficerTigard, OR
Scott William IglExecutive OfficerTigard, OR
Shawn William MacDonaldExecutive OfficerTigard, OR
Matt BeaudetDirectorTigard, OR
Matt BeaudetExecutive OfficerTigard, OR
Kirk MalloyDirectorTigard, OR
Sean O'NeillDirectorWALTHAM, MA
Shawn MacDonaldExecutive OfficerTigard, OR
Samraat RahaDirectorTigard, OR
Kevin GabeleinDirectorTigard, OR
J. William FreytagDirectorTigard, OR
William CortelyouDirectorTigard, OR
Bruce RhineDirectorTigard, OR

Other filings by this issuer (2)

FiledFormOfferingSold
2025-12-09D/A$14.1M$12.2M
2025-01-15D$8.0M$2.5M

More